Long-Term Persistence of BCG Pasteur in Lungs of C57BL/6 Mice Following Intranasal Infection

Scandinavian Journal of Immunology

Volumn 75, Issue 5, 2012, Pages 489-499

  Leversen, N A ^a   Sviland, L ^a   Wiker, H G ^a,b   Mustafa, T ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BCG VACCINATION; CELL ISOLATION; COLONY FORMING UNIT; DISEASE COURSE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUBERCULOSIS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BCG VACCINE; FEMALE; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS;

EID: 84859378694     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02683.x     Document Type: Article

References (41)

1. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis 1998;2:200-7.
2. Colditz GA, Brewer TF, Berkey CS et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702.
3. Aronson NE, Santosham M, Comstock GW et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA 2004;291:2086-91.
4. Harboe M, Nagai S. MPB70, a unique antigen of Mycobacterium bovis BCG. Am Rev Respir Dis 1984;129:444-52.
5. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991;59:372-82.
6. Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M. Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG. Infect Immun 1993;61:1730-4.
7. Behr MA, Wilson MA, Gill WP et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;5419:1520-3.
8. Brosch R, Gordon SV, Garnier T et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A 2007;104:5596-601.
9. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 1996;5:1274-82.
10. Wiker HG, Nagai S, Hewinson RG, Russell WP, Harboe M. Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv. Scand J Immunol 1996;43:374-80.
11. Wiker HG. MPB70 and MPB83 - major antigens of Mycobacterium bovis. Scand J Immunol 2009;69:492-9.
12. Brosch R, Gordon SV, Buchrieser C, Pym AS, Garnier T, Cole ST. Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast 2000;17:111-23.
13. Chen JM, Islam ST, Ren H, Liu J. Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety. Vaccine 2007;25:8114-22.
14. Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ 1990;68:93-108.
15. Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 2008;32:821-41.
16. Irwin SM, Goodyear A, Keyser A et al. Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model. Clin Vaccine Immunol 2008;15:750-6.
17. Saxena RK, Weissman D, Simpson J, Lewis DM. Murine model of BCG lung infection: dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes. J Bio sci 2002;27:143-53.
18. Fulton SA, Martin TD, Redline RW, Boom WH. Pulmonary immune responses during primary Mycobacterium bovis Calmette-Guerin bacillus infection in C57Bl/6 mice. Am J Respir Cell Mol Biol 2000;22:333-43.
19. Wakeham J, Wang J, Xing Z. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice. Infect Immun 2000;68:6946-53.
20. Swensson A, Göthe CJ, Nyström B. Survival of BCG in rat tissues. Int Arch Arbeitsmed 1971;28:296-300.
21. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 1997;78:57-66.
22. Mustafa T, Phyu S, Nilsen R, Jonsson R. A mouse model for slowly progressive primary tuberculosis. Scand J Immunol 1999;50:127-36.
23. Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. J Immunol 2010;185:15-22.
24. Logan KE, Gavier-Widen D, Hewinson RG, Hogarth PJ. Development of a Mycobacterium bovis intranasal challenge model in mice. Tuberculosis 2008;88:437-43.
25. Romain F, Laqueyrerie a, Militzer P et al. Identification of a Mycobacterium bovis BCG 45/47-Kilodalton antigen complex, an immunodominant target for antibody-response after immunization with living bacteria. Infect Immun 1993;61:742-50.
26. Wieles B, Nagai S, Wiker HG, Harboe M, Ottenhoff TH. Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis. Infect Immun 1995;63:4946-8.
27. Manca C, Lyashchenko K, Wiker H, Usai D, Colangeli R, Gennaro M. Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun 1997;65:16-23.
28. Shinnick TM, Vodkin MH, Williams JC. The Mycobacterium tuberculosis 65-kilodalton antigen is a heat shock protein which corresponds to common antigen and to the Escherichia coli GroEL protein. Infect Immun 1988;56:446-51.
29. Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, Magnusson M. The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system. Scand J Immunol 1980;12:249-63.
30. Kozak R, Behr MA. Divergence of immunologic and protective responses of different BCG strains in a murine model. Vaccine 2011;29:1519-26.
31. Kernodle DS. Decrease in the effectiveness of Bacille Calmette-Guérin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation. Clin Infect Dis 2010;51:177-84.
32. Sadagopal S, Braunstein M, Hager CC et al. Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. PLoS One 2009;4:e5531.
33. Edwards KM, Cynamon MH, Voladri RK et al. Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2001;164:2213-9.
34. Kurtz S, McKinnon KP, Runge MS, Ting JPY, Braunstein M. The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response. Infect Immun 2006;74:6855-64.
35. Jain R, Dey B, Khera A et al. Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses. Vaccine 2011;29:8118-25.
36. Hayashi D, Takii T, Fujiwara N et al. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains. FEMS Immunol Med Microbiol 2009;56:116-28.
37. Tschernig T, Pabst R. Bronchus-Associated Lymphoid Tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000;68:1-8.
38. Sminia T, van derBrugge-Gamelkoorn GJ, Jeurissen SH. Structure and function of bronchus-associated lymphoid tissue (BALT). Crit Rev Immunol 1989;9:119-50.
39. Phyu S, Mustafa T, Hofstad T, Nilsen R, Fosse R, Bjune G. A mouse model for latent tuberculosis. Scand J Infect Dis 1998;30:59-68.
40. Hernández-Pando R, Jeyanathan M, Mengistu G et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000;356:2133-8.
41. Wayne LG, Sohaskey CD. Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol 2001;55:139-63.